SYM-002 (Symmune Therapeutics)

N/A

Report date: 2025/03/20 15:26:52
NME

Base Information

Drug NameSYM-002 (Symmune Therapeutics)
Drug Alias NameSYM-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsRhinitis, AllergicInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSymmune Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesSymmune Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsRhinitis, AllergicInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A